Front Page News

Team Cure SMA Completes the 2019 Falmouth Road Race in Cape Cod

August 28, 2019
Posted in ,

Twenty Team Cure SMA runners completed the 2019 Falmouth Road Race on Sunday, August 18. Together, the runners successfully raised over $52,000 for Cure SMA, […]

Read More ›

2019 SMA Researcher Meeting Summary: Basic Research Podium Presentations

August 26, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

Thank You for a Wonderful 2019 Annual SMA Conference!

August 15, 2019
Posted in ,

Thank you to everyone who attended the 2019 Annual SMA Conference at the Disneyland in Anaheim, California! It was an impactful weekend of community, research […]

Read More ›

Cure SMA Awards Grants to Four States to Expediate the Implementation of SMA Newborn Screening

August 13, 2019
Posted in , ,

On July 3, 2018, Health and Human Services Secretary Alex Azar approved the recommendation that newborn screening for spinal muscular atrophy be implemented nationwide. This recommendation was […]

Read More ›

2019 SMA Researcher Meeting Summary: Special Session on Spinal and Neuromuscular Circuitry: Exploring Defects in SMA and Potential Therapeutic Targets

August 12, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

Cure SMA Update on Data Accuracy Issues with AveXis’ SMA Therapy, Zolgensma

August 9, 2019
Posted in

Earlier this week, the FDA issued a statement identifying data accuracy issues with AveXis’ SMA therapy, Zolgensma. Cure SMA immediately opened an investigation into the […]

Read More ›

Cure SMA Releases Status Update on Data Accuracy Issues with Zolgensma

August 7, 2019
Posted in

Yesterday, the FDA issued a statement identifying data accuracy issues with Avexis’ SMA therapy, Zolgensma. Cure SMA is in communication with the FDA and is committed to […]

Read More ›

FDA Issues Statement on Data Accuracy Issues with Recently Approved Gene Therapy

August 6, 2019
Posted in

Today, the FDA issued the below statement identifying data accuracy issues with AveXis’ SMA therapy, Zolgensma. Cure SMA is investigating this issue and will report when we have […]

Read More ›

Biogen Issues Community Statement on Spinraza

August 5, 2019
Posted in ,

Biogen has provided the following community statement on Spinraza. Dear members of the SMA community, Following a busy spring of data presentations at medical congresses […]

Read More ›

SMA Awareness Month 2019 Has Begun!

August 1, 2019
Posted in ,

SMA Awareness Month occurs in August! The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month and Cure SMA has been coordinating activities […]

Read More ›
Scroll to Top